Cargando…

Levels of clinical condom failure for anal sex: A randomized cross-over trial

BACKGROUND: Men who have sex with men (MSM) face a 28-fold higher risk of HIV acquisition than men who have sex with women (MSW). Condoms are the most accessible prevention method, with billions produced annually. Due to potentially high clinical failure, international regulatory agencies do not app...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegler, Aaron J., Rosenthal, Elizabeth M., Sullivan, Patrick S., Christina Mehta, C., Moore, Reneé H., Ahlschlager, Lauren, Kelley, Colleen F., Rosenberg, Eli S., Cecil, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933145/
https://www.ncbi.nlm.nih.gov/pubmed/31891134
http://dx.doi.org/10.1016/j.eclinm.2019.10.012
_version_ 1783483146444996608
author Siegler, Aaron J.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Christina Mehta, C.
Moore, Reneé H.
Ahlschlager, Lauren
Kelley, Colleen F.
Rosenberg, Eli S.
Cecil, Michael P.
author_facet Siegler, Aaron J.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Christina Mehta, C.
Moore, Reneé H.
Ahlschlager, Lauren
Kelley, Colleen F.
Rosenberg, Eli S.
Cecil, Michael P.
author_sort Siegler, Aaron J.
collection PubMed
description BACKGROUND: Men who have sex with men (MSM) face a 28-fold higher risk of HIV acquisition than men who have sex with women (MSW). Condoms are the most accessible prevention method, with billions produced annually. Due to potentially high clinical failure, international regulatory agencies do not approve condoms for anal sex. This trial sought to provide data regarding approval of condoms for anal sex. METHODS: We conducted a blinded, crossover randomized trial among MSM and MSW in Atlanta, Georgia, USA. Crossover conditions were standard condoms, thin condoms, and condoms fitted to each user's penile dimensions. The primary outcome was total clinical failure (slippage and/or breakage), assessed using an intention-to-treat analysis. A mixed methods model assessed differences in odds of failure. The study is registered with ClinicalTrials.gov, NCT02753842, and is completed. FINDINGS: We enrolled 252 MSM and 252 MSW between May 19, 2016 and May 2, 2017. Participants reported a total of 4884 anal or vaginal sex acts using study-provided condoms. For all crossover conditions, clinical failure was lower for anal sex (0•7%, 16/2351) than for vaginal sex (1•9%, 48/2533), (odds ratio 0•40, 95% confidence interval 0•21, 0•75, p < •001)00. There was no difference in odds of failure for anal sex acts between the different types of condoms. Due to study design, nearly all anal sex acts used condom-compatible lubricant (98•3%), yet only a minority of vaginal sex acts (41•6%) used lubricant. Sex acts for which lubricant was used had lower failure for both anal and vaginal sex, with no difference in odds of failure between them. INTERPRETATION: In the largest trial of effectiveness of condoms for anal sex to date, we found remarkably low levels of failure. Condoms should be approved by regulatory agencies for anal sex. Clinicians may recommend condoms as a highly efficacious HIV and STD prevention tool for anal sex. Differences between failure for anal and vaginal sex were likely due to differential use of lubricant. Condom promotion programs should consider providing additional lubricant for all condoms distributed.
format Online
Article
Text
id pubmed-6933145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69331452019-12-30 Levels of clinical condom failure for anal sex: A randomized cross-over trial Siegler, Aaron J. Rosenthal, Elizabeth M. Sullivan, Patrick S. Christina Mehta, C. Moore, Reneé H. Ahlschlager, Lauren Kelley, Colleen F. Rosenberg, Eli S. Cecil, Michael P. EClinicalMedicine Research Paper BACKGROUND: Men who have sex with men (MSM) face a 28-fold higher risk of HIV acquisition than men who have sex with women (MSW). Condoms are the most accessible prevention method, with billions produced annually. Due to potentially high clinical failure, international regulatory agencies do not approve condoms for anal sex. This trial sought to provide data regarding approval of condoms for anal sex. METHODS: We conducted a blinded, crossover randomized trial among MSM and MSW in Atlanta, Georgia, USA. Crossover conditions were standard condoms, thin condoms, and condoms fitted to each user's penile dimensions. The primary outcome was total clinical failure (slippage and/or breakage), assessed using an intention-to-treat analysis. A mixed methods model assessed differences in odds of failure. The study is registered with ClinicalTrials.gov, NCT02753842, and is completed. FINDINGS: We enrolled 252 MSM and 252 MSW between May 19, 2016 and May 2, 2017. Participants reported a total of 4884 anal or vaginal sex acts using study-provided condoms. For all crossover conditions, clinical failure was lower for anal sex (0•7%, 16/2351) than for vaginal sex (1•9%, 48/2533), (odds ratio 0•40, 95% confidence interval 0•21, 0•75, p < •001)00. There was no difference in odds of failure for anal sex acts between the different types of condoms. Due to study design, nearly all anal sex acts used condom-compatible lubricant (98•3%), yet only a minority of vaginal sex acts (41•6%) used lubricant. Sex acts for which lubricant was used had lower failure for both anal and vaginal sex, with no difference in odds of failure between them. INTERPRETATION: In the largest trial of effectiveness of condoms for anal sex to date, we found remarkably low levels of failure. Condoms should be approved by regulatory agencies for anal sex. Clinicians may recommend condoms as a highly efficacious HIV and STD prevention tool for anal sex. Differences between failure for anal and vaginal sex were likely due to differential use of lubricant. Condom promotion programs should consider providing additional lubricant for all condoms distributed. Elsevier 2019-10-31 /pmc/articles/PMC6933145/ /pubmed/31891134 http://dx.doi.org/10.1016/j.eclinm.2019.10.012 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Siegler, Aaron J.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Christina Mehta, C.
Moore, Reneé H.
Ahlschlager, Lauren
Kelley, Colleen F.
Rosenberg, Eli S.
Cecil, Michael P.
Levels of clinical condom failure for anal sex: A randomized cross-over trial
title Levels of clinical condom failure for anal sex: A randomized cross-over trial
title_full Levels of clinical condom failure for anal sex: A randomized cross-over trial
title_fullStr Levels of clinical condom failure for anal sex: A randomized cross-over trial
title_full_unstemmed Levels of clinical condom failure for anal sex: A randomized cross-over trial
title_short Levels of clinical condom failure for anal sex: A randomized cross-over trial
title_sort levels of clinical condom failure for anal sex: a randomized cross-over trial
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933145/
https://www.ncbi.nlm.nih.gov/pubmed/31891134
http://dx.doi.org/10.1016/j.eclinm.2019.10.012
work_keys_str_mv AT siegleraaronj levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT rosenthalelizabethm levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT sullivanpatricks levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT christinamehtac levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT moorereneeh levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT ahlschlagerlauren levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT kelleycolleenf levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT rosenbergelis levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial
AT cecilmichaelp levelsofclinicalcondomfailureforanalsexarandomizedcrossovertrial